Gastrodin alleviates cisplatin nephrotoxicity by inhibiting ferroptosis via the SIRT1/FOXO3A/GPX4 signaling pathway
- 4 October 2023
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 3) , 117282
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ferroptosis as a target for protection against cardiomyopathyProceedings of the National Academy of Sciences, 2019
- Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial functionEBioMedicine, 2018
- Ferroptosis as a p53-mediated activity during tumour suppressionNature, 2015
- Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in miceNature Cell Biology, 2014
- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's diseaseHuman Molecular Genetics, 2014
- Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-κB signaling activation in CD4+ T cellsToxicology and Applied Pharmacology, 2013
- Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating CatalaseJournal of Biological Chemistry, 2008
- Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 DeacetylaseScience, 2004
- Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stressNature, 2002
- Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatinClinical Pharmacology & Therapeutics, 1986